Abstract
Multiple sclerosis (MS) is one of the numerous human inflammatory diseases with suspected, though not formally confirmed autoimmune pathogenesis. It is clear that MS is not caused by humoral autoantibodies, which definitely have a central effector function in diseases such as myasthenia gravis and pemphigoid. It appears rather that the immunopathological changes typically seen in the myelinated parts of the central nervous system (CNS) are caused by cellular rather than by humoral autoimmune mechanisms. There are diverse lines of evidence suggesting that autoaggressive T cells cause MS by attacking the body’s own myelinated tissues. These include the association of disease susceptibility with certain haplotypes of the major histocompatibility complex (MHC), in particular with its class II genes. Second, the histological changes in the MS lesion are highly suggestive of a T cell mediated inflammatory reaction (see below). These changes share essential features with experimental autoimmune encephalomyelitis (EAE), a myelin-specific autoimmune disease inducible in animals by immunization against myelin components.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acha-Orbea H, Mitchell DJ, Timmermann L, Wraith DC, Tausch GS, Waldor MK, Zamvil SS, McDevitt HO, Steinmann L (1988) Limited heterogeneity of T cell receptors from T lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54: 263–273
Ben-Nun A, Cohen IR (1982) Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol 129: 303–308
Ben-Nun A, Wekerle H, Cohen IR (1981) The rapid isolation of clonable antigen-specific T lymphocytes capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11: 195–199
Ben-Nun A, Lando Z, Dorf ME, Burakoff SJ (1983) Analysis of cross-reactive antigen-specific T cell clones. Specific recognition of two major histocompatibility complex (MHC) and two non-MHC antigens by a single clone. J Exp Med 147: 2147–2153
Burns J, Rosenzweig A, Zweiman B, Lisak RP (1983) Isolation of myelin basic protein-reactive T cell lines from normal human blood. Cell Immunol 81: 435–440
Burns FR, Li X, Shen H, Offner H, Chou YK, Vandenbark AA, Heber-Katz E (1989) Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Va and Vβ chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J Exp Med 169: 27–40
Chluba J, Steeg C, Becker A, Wekerle H, Epplen JT (1989) T cell receptor β chain usage in myelin basic protein-specific rat T lymphocytes. Eur J Immunol 19: 279–284
Chou YK, Vainiene M, Whitham RH, Bourdette DN, Chou C-HJ, Hashim G, Offner H, Vandenbark AA (1989) Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules. J Neurosci Res 23: 207–216
Chou YK, Henderikx P, Vainiene M, Whitham R, Bourdette D, Chou CH-J, Hashim G, Offner H, Vandenbark AA (1991) Specificity of human T clones reactive to immunodominant epitopes of myelin basic protein. J Neurosci Res 28: 280–290
Compston DAS (1986) Genetic factors in the etiology of multiple sclerosis. In: McDonald WI, Silberberg DH (eds) Multiple sclerosis. Butterworths, London, pp 56–73
Davis MM, Bjorkman PJ (1988) T-cell antigen receptor genes and T-cell recognition. Nature 334: 395–402
Fallis RJ, McFarlin DE (1989) Chronic relapsing experimental allergic encephalomyelitis: cytotoxicity effected by a class II-restricted T cell line specific for an encephalitogenic epitope. J Immunol 143: 2160–2165
Fling SP, Donoso LA, Gregerson DS (1991). In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen. J Immunol 147: 483–489
Fontana A, Fierz W, Wekerle H (1984) Astrocytes present myelin basic protein to encephalitogenic T cell lines. Nature 307: 273–275
Fritz RB, McFarlin DE (1989) Encephalitogenic epitopes of myelin basic protein. In: Sercarz E (ed) Antigenic determinants and immune regulation. Karger, Basel, pp 101–125
Giegerich G, Pette M, Meinl E, Epplen JT, Wekerle H, Hinkkanen A (1992). Diversity of T cell receptor a and β chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes. Eur J Immunol 22: 753–758
Hashim GA (1977) Experimental allergic encephalomyelitis in Lewis rats: chemical synthesis of disease-inducing determinant. Science 196: 1219–1221
Holda JH, Swanborg RH (1982) Autoimmune effector cells. II. Transfer of experimental allergic encephalomyelitis with a subset of T lymphocytes. Eur J Immunol 12: 453–455
Holoshitz J, Frenkel A, Ben-Nun A, Cohen IR (1983) Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein.Vaccination is determinant specific. J Immunol 131: 2810–2813
Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW (1989). Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246: 668–671
Jaraquemada D, Martin R, Rosen-Bronson S, Flerlage M, McFarland HF, Long EO (1990) HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J Immunol 145: 2880–2885
Kibler RF, Fritz RB, Chou FC-H, Chou C-HJ, Peacocke NY, Brown NM, McFarlin DE (1977) Immune response of Lewis rats to peptide CI (residues 68–88) of guinea pig and rat myelin basic proteins. J Exp Med 146: 1323–1331
Kotake S, Wiggert B, Zhang X-Y, Redmond TM, Chader GJ, Gery I (1990) Stimulation in vitro of lymphocytes for induction of uveoretinitis without any significant proliferation. J Immunol 145: 534–539
Kotzin BL, Karuturi S, Chou YK, Lafferty J, Forrester JM, Better M, Nedwin GE, Offner H, Vandenbark AA (1991) Preferential T-cell receptor β-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 88: 9161–9165
Lassmann H (1983) Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Springer, Berlin Heidelberg New York
Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130: 443–454
Mannie MD, Paterson PY, U’Pritchard DC, Flouret G (1985) Induction of experimental allergic encephalomyelitis (EAE) in the Lewis rat with purified synthetic peptides: delineation of antigen determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes. Proc Natl Acad Sci USA 82: 5515–5519
Martin R, Jaraquemada D, Flerlage M, Richert JR, Whitaker J, Long EO, McFarlin DE, McFarland HF (1990) Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 145: 540–548
Martin R, Howell MD, Jaraquemada D, Flerlage M, Richert J, Brostoff S, Long EO, McFarlin DE, McFarland HF (1991) A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 173: 19–24
Martin R, Utz U, Coligan JE, Richert JR, Flerlage M, Robinson E, Stone R, Biddison WE, McFarlin DE, McFarland HF (1992) Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87–106. J Immunol 148: 1359–1366
Meinl E, Saruhan G, Weber F, Schönbeck S, Goebels N, Bröhm M, Hohlfeld R, Wekerle H (1991) Multiple sclerosis: heterogeneity of T cell-receptors used by human T lymphocytes specific for myelin basic protein. Neurology 43 [Suppl 1]: 257 (abstract)
Offner H, Hashim GA, Vandenbark AA (1991) T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251: 430–432
Oksenberg JR, Stuart S, Begovich AB, Bell RB, Erlich HA, Steinman L, Bernard CCA (1990) Limited heterogeneity of rearranged T-cell receptor Va transcripts in brains of multiple sclerosis patients. Nature 345: 344–346
Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA (1990) T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346: 183–187
Paterson PY (1960) Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111: 119–135
Pette M, Fujita K, Kitze B, Whitaker JN, Albert E, Kappos L, Wekerle H (1990 a) Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40: 1770–1776
Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G, Hinkkanen A, Epplen JT, Kappos L, Wekerle H (1990 b) Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc Natl Acad Sci USA 87: 7968–7972
Pettinelli CB, McFarlin DE (1981) Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells with myelin basic protein: requirement for Lyt-l+2-T lymphocytes. J Immunol 127: 1420–1423
Raine CS (1984) Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 50: 608–635
Richert JR, Robinson ED, Deibler GE, Martenson RE, Dragovic LJ, Kies MW (1989 a) Evidence for multiple human T cell recognition sites on myelin basic protein. J Neuroimmunol 23: 55–66
Richert JR, Robinson ED, Deibler GE, Martenson RE, Dragovic LJ, Kies MW (1989b) Human cytotoxic T-cell recognition of a synthetic peptide of myelin basic protein. Ann Neurol 26: 342–346
Richert JR, Robinson ED, Johnson AH, Bergman CA, Dragovic LJ, Reinsmoen NL, Hurley CK (1991) Heterogeneity of the T cell receptor β gene rearrangements generated in myelin basic protein-specific T cell clones isolated from a patient with multiple sclerosis. Ann Neurol 29: 299–306
Schluesener HJ, Wekerle H (1985) Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. J Immunol 135: 3128–3133
Sun D, Wekerle H (1986) la-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature 320: 70–72
Tournier-Lasserve E, Hashim G, Bach MA (1988) Human T-cell response to myelin basic protein in multiple sclerosis patients and healthy subjects. J Neurosci Res 19: 149–156
Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, Ando DG, Sercarz EE, Hood L (1988) Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54: 577–592
Vandenbark AA, Hashim G, Offner H (1989) Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341: 541–544
Weber WEJ, Buurman WA (1988) In vitro functional blocking of myelin basic protein-specific cytolytic human T lymphocyte clones by immunosuppressive drugs and monoclonal antibodies. J Neuroimmunol 22: 1–10
Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Cellular immune reactivity within the CNS. Trends Neurosci 9: 271–277
Wekerle H, Pette M, Fujita K, Nomura K, Meyermann R (1989) Autoimmunity in the nervous system: functional properties of an encephalitogenic protein. Prog Immunol 7: 813–820
Wilkinson D, De Vries RRP, Madrigal JA, Lock CB, Morgenstern JP, Trowsdale J, Altmann DM (1988) Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2β gene products and antigen presentation to T cell clones from leprosy patients. J Exp Med 167: 1442–1458
Wucherpfennig KW, Ota K, Endo N, Seidman JG, Rosenzweig A, Weiner HL, Hafler DA (1990) Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 248: 1016–1019
Wucherpfennig KW, Weiner HL, Hafler DA (1991) T-cell recognition of myelin basic protein. Immunol Today 12: 277–282
Wucherpfennig KW, Newcombe J, Li H, Keddy C, Cuzner ML, Hafler DA (1992) T cell receptor Vα-Vβ repertoire and cytokine gene expression in active multiple sclerosis lesions. J Exp Med 175: 993–1002
Zamvil SS, Mitchell DJ, Moore AC, Schwarz AJ, Stiefel W, Nelson PA, Rothbard JB, Steinman L (1987) T cell reactivity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein. J Immunol 139: 1075–1079
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wekerle, H. (1993). Myelin-Specific Autoimmune T Cells in the Pathogenesis of Multiple Sclerosis: Their Characteristics and Possible Approaches to Immunospecific Therapy. In: Eibl, M.M., Huber, C., Peter, H.H., Wahn, U. (eds) Symposium in Immunology I and II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78087-5_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-78087-5_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56478-2
Online ISBN: 978-3-642-78087-5
eBook Packages: Springer Book Archive